Endesa SA (0N9G)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 43.93 |
|---|---|
| 52-week range | 29.19 – 43.93 |
| Return, 1 month / 3 months | +3.2% / +7.4% |
| Return, 1 year / 3 years | +53.9% / +178.2% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 20.8% |
| Worst drawdown (1 year) | -8.0% |
| Average daily value traded | 5.07M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Endesa is a Spanish electricity and gas company based in Madrid. It generates power from a mix of sources, operates electricity distribution networks, and supplies electricity and gas to homes, businesses and public bodies, mainly in Spain and Portugal. Its activities cover the whole chain from producing energy through to metering and customer service, and it also runs related operations in other European markets.
The shares are listed on the London Stock Exchange in UK under the code 0N9G, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Endesa SA (0N9G) trades on the London Stock Exchange in UK. It last closed at EUR 43.93 on 27 October 2026.
Its price-based Market X-Ray is 82 out of 100 (a strong price profile), ranking 32 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 53.9% and over the last three months it rose 7.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 17.4% | ||
| From 52-week high | 0.0% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.4% | ||
| 6-month return | 17.1% | ||
| 12-month return, skipping the last month | 49.1% | ||
| Stability (higher is calmer) | 91 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -8.0% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 5.07M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 67 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | +3.2% |
| 3 months | +7.4% |
| 6 months | +17.1% |
| 1 year | +53.9% |
| 3 years | +178.2% |
| 5 years | +182.9% |
Signals
| 50-day / 200-day average | 42.18 / 37.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Jul 2026 | EUR 0.8780 |
| 8 Jan 2026 | EUR 0.4050 |
| 27 Jun 2025 | EUR 0.6623 |
| 6 Jan 2025 | EUR 0.4050 |
| 27 Jun 2024 | EUR 0.4050 |
| 28 Dec 2023 | EUR 0.4050 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.